Letter Regarding Article by Tsimikas et al, "High-Dose Atorvastatin Reduces Total Plasma Levels of Oxidized Phospholipids and Immune Complexes Present on Apolipoprotein B-100 in Patients With Acute Coronary Syndromes in the MIRACL Trial" * Response
van Tits, L. J.Volume:
111
Language:
english
Journal:
Circulation
DOI:
10.1161/01.CIR.0000164264.00913.6D
Date:
May, 2005
File:
PDF, 35 KB
english, 2005